View of Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways

Return to Article Details Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways Download Download PDF